Investor mix
4 investors on record; lead investors include Swanbridge Capital, Curie Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 50% |
| Accelerator & incubator | 1 | 25% |
| Other / undisclosed | 1 | 25% |
Developer of immunotherapies for allergy and autoimmune disease
4 investors on record; lead investors include Swanbridge Capital, Curie Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 50% |
| Accelerator & incubator | 1 | 25% |
| Other / undisclosed | 1 | 25% |